CHINA SXT PHARMACEUTICALS, INC. (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt SecuritiesChina SXT Pharmaceuticals, Inc. • February 2nd, 2021 • Pharmaceutical preparations • New York
Company FiledFebruary 2nd, 2021 Industry JurisdictionINDENTURE, dated as of [●], 20[●], among China SXT Pharmaceuticals, Inc., a British Virgin Islands corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
CHINA INTERNET NATIONWIDE FINANCIAL SERVICES INC. Issuer AND [Trustee], Trustee INDENTURE Dated as of [●], 20[●] Subordinated Debt IndentureChina Internet Nationwide Financial Services, Inc. • September 11th, 2019 • Services-management consulting services • New York
Company FiledSeptember 11th, 2019 Industry JurisdictionIndenture, dated as of [●], 20[●], among China Internet Nationwide Financial Services Inc., a British Virgin Islands exempted company (the “Company”), and [Trustee], as trustee (the “Trustee”):
ARDEA BIOSCIENCES, INC. AND [TRUSTEE], TRUSTEE FORM OF SUBORDINATED DEBT INDENTUREArdea Biosciences, Inc./De • December 23rd, 2011 • Pharmaceutical preparations • New York
Company FiledDecember 23rd, 2011 Industry JurisdictionINDENTURE, dated as of , 20 , among ARDEA BIOSCIENCES, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
HALOZYME THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF ___, 20__ SUBORDINATED DEBT SECURITIESHalozyme Therapeutics Inc • January 5th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 5th, 2010 Industry Jurisdictionindenture, dated as of [•], 200___, among Halozyme Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
HALOZYME THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF ___, 20___ SENIOR DEBT SECURITIESHalozyme Therapeutics Inc • January 5th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 5th, 2010 Industry JurisdictionINDENTURE, dated as of [•], 20[•], among Halozyme Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
Brocade Communications Systems, Inc., Issuer AND , Trustee INDENTURE Dated as of ___, 200___ Subordinated Debt SecuritiesBrocade Communications Systems Inc • August 26th, 2008 • Computer peripheral equipment, nec • New York
Company FiledAugust 26th, 2008 Industry JurisdictionIndenture, dated as of ___, 200___, among Brocade Communications Systems, Inc., a Delaware corporation (the “Company”), and , as trustee (the “Trustee”):
XO HOLDINGS, INC., Issuer AND [ ], Trustee INDENTURE Dated as of [___], 200[___] Senior Debt SecuritiesXo Holdings Inc • November 27th, 2007 • Telephone communications (no radiotelephone) • New York
Company FiledNovember 27th, 2007 Industry Jurisdiction* This Table of Contents does not constitute part of the Indenture and shall not have any bearing upon the interpretation of any of its terms or provisions.
MARTEK BIOSCIENCES CORPORATION ISSUER AND WACHOVIA BANK, NATIONAL ASSOCIATION TRUSTEEMartek Biosciences Corp • May 21st, 2004 • Biological products, (no disgnostic substances) • New York
Company FiledMay 21st, 2004 Industry JurisdictionINDENTURE, dated as of [ ], [ ], between MARTEK BIOSCIENCES CORPORATION, a Delaware corporation (the “Company”), and Wachovia Bank, National Association, as trustee (the “Trustee”):